Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
10.00
-0.04 (-0.40%)
At close: Oct 26, 2026, 4:00 PM EDT
9.87
-0.13 (-1.30%)
After-hours: Oct 26, 2026, 7:49 PM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $1.22 billion as of October 26, 2026. It is the 9,017th most valuable company in the world and the 2,103rd biggest in the United States. Its market cap has increased by 148.32% in one year.
Market Cap
1.22B
Enterprise Value
1.16B
1-Year Change
148.32%
Global Rank
Country Rank
#2,103 United States
Category
ChartMarket Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $224.40M to $1.22B, an increase of 441.46%. That is a compound annual growth rate of 12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.22B | 103.91% |
| Dec 31, 2025 | 595.84M | 158.95% |
| Dec 31, 2024 | 230.10M | 11.87% |
| Dec 29, 2023 | 205.68M | 143.23% |
| Dec 30, 2022 | 84.56M | -77.36% |
| Dec 31, 2021 | 373.48M | 3.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 1.28B |
| Nektar Therapeutics | 1.28B |
| Rapport Therapeutics | 1.27B |
| Avalyn Pharma | 1.23B |
| Alpha Tau Medical | 1.21B |
| Omeros | 1.20B |
| Kardigan | 1.20B |
| Syndax Pharmaceuticals | 1.19B |